Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Post-marketing Safety Measures

Revisions of PRECAUTIONS (FY2024)

Posted date Nonproprietary name
(Click on each drug name for more information
[only  in Japanese ])
Detailed information on revisions of PRECAUTIONS
(from MHLW)
Summary of
investigation results
(from PMDA)
Reference article (Important Safety Information) in Pharmaceuticals and Medical Devices Safety Information (PMDSI)
April 9, 2024 Bisoprolol fumarate PRECAUTIONS [152 KB] Report on Investigation [248 KB]
Appendix 4 is not included in this file. See  PRECAUTIONS.
 
Bisoprolol PRECAUTIONS [153 KB]  
Carvedilol PRECAUTIONS [149 KB] Report on Investigation [236 KB]
Appendix 4 is not included in this file. See  PRECAUTIONS.